| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |